Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
出版年份 2016 全文链接
标题
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
作者
关键词
-
出版物
JOURNAL OF NEUROCHEMISTRY
Volume 139, Issue -, Pages 290-317
出版商
Wiley
发表日期
2015-10-10
DOI
10.1111/jnc.13390
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cerebrospinal Fluid α-Synuclein Does Not Discriminate Between Dementia Disorders
- (2017) Petra E. Spies et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- The Glymphatic System: A Beginner’s Guide
- (2015) Nadia Aalling Jessen et al. NEUROCHEMICAL RESEARCH
- Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease
- (2015) Ane Løvli Stav et al. PARKINSONISM & RELATED DISORDERS
- Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Issue of Diurnal Variation
- (2015) Claudia Cicognola et al. Frontiers in Neurology
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
- (2014) Yaroslau Compta et al. JOURNAL OF NEUROLOGY
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
- (2014) Jan O. Aasly et al. Frontiers in Aging Neuroscience
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
- (2014) Abid Oueslati et al. Experimental Neurobiology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology
- (2013) Sibylle E. Eisbach et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Movement disorders in cerebrovascular disease
- (2013) Raja Mehanna et al. LANCET NEUROLOGY
- Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease
- (2013) Mona K. Beyer et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort
- (2013) B. Mollenhauer et al. NEUROLOGY
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
- (2013) Malin Wennström et al. PLoS One
- The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer’s Disease
- (2013) Elisabeth Kapaki et al. PLoS One
- Sleep Drives Metabolite Clearance from the Adult Brain
- (2013) L. Xie et al. SCIENCE
- CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
- (2012) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Aβ and Tau Level Fluctuation in an Older Clinical Cohort
- (2012) Abhay Moghekar ARCHIVES OF NEUROLOGY
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma
- (2012) Carl P.C. Chen et al. EXPERIMENTAL GERONTOLOGY
- Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy
- (2012) Kiren Ubhi et al. EXPERIMENTAL NEUROLOGY
- Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies
- (2012) Hans Brunnström et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Dementia From Alzheimer Disease and Mixed Pathologies in the Oldest Old
- (2012) Bryan D. James JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel One-step Immunoassays to Quantify α-Synuclein
- (2012) Michael Bidinosti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
- (2012) Brit Mollenhauer et al. JOURNAL OF NEURAL TRANSMISSION
- Cerebrospinal fluid amyloid- and phenotypic heterogeneity in de novo Parkinson's disease
- (2012) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Exosomal cell-to-cell transmission of alpha synuclein oligomers
- (2012) Karin M Danzer et al. Molecular Neurodegeneration
- Neurodegeneration in Parkinson disease: Moving Lewy bodies out of focus
- (2012) W. J. Schulz-Schaeffer NEUROLOGY
- Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
- (2012) J. M. Milber et al. NEUROLOGY
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
- (2012) S. N. Gomperts et al. NEUROLOGY
- Age and diagnostic performance of Alzheimer disease CSF biomarkers
- (2012) N. Mattsson et al. NEUROLOGY
- Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
- (2012) Magdalena Nutu et al. NEUROMOLECULAR MEDICINE
- Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
- (2012) Brit Mollenhauer et al. NEUROSCIENCE LETTERS
- The Spread of Neurodegenerative Disease
- (2012) John Hardy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
- (2012) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Neuropathology underlying clinical variability in patients with synucleinopathies
- (2011) Glenda M. Halliday et al. ACTA NEUROPATHOLOGICA
- The neurotransmitter serotonin interrupts α-synuclein amyloid maturation
- (2011) S. Fabio Falsone et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- CSF biomarkers in different phenotypes of Parkinson disease
- (2011) Kurt A. Jellinger JOURNAL OF NEURAL TRANSMISSION
- Tau protein and beta-amyloid1-42 CSF levels in different phenotypes of Parkinson’s disease
- (2011) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- CSF α-synuclein, tau, and amyloid β in Parkinson's disease
- (2011) Min Shi et al. LANCET NEUROLOGY
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers
- (2011) Diane Slats et al. NEUROBIOLOGY OF AGING
- CSF tau markers are correlated with hippocampal volume in Alzheimer's disease
- (2011) Leonardo C. de Souza et al. NEUROBIOLOGY OF AGING
- CSF α-synuclein does not differentiate between parkinsonian disorders
- (2011) M.B. Aerts et al. NEUROBIOLOGY OF AGING
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
- (2011) P.G. Foulds et al. NEUROBIOLOGY OF DISEASE
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- CSF α-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid β in humans
- (2011) Petra E. Spies et al. NEUROSCIENCE LETTERS
- Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- (2011) Sara Bech et al. PARKINSONISM & RELATED DISORDERS
- Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
- (2011) Marios Politis et al. TheScientificWorldJOURNAL
- Biomarkers in Alzheimer’s Disease
- (2011) Mario Riverol et al. Frontiers in Neurology
- Prevalence of dementia disorders in the oldest-old: an autopsy study
- (2010) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses
- (2010) Hans Brunnström et al. Alzheimers & Dementia
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
- (2010) Geert De Meyer ARCHIVES OF NEUROLOGY
- Biomarker research in Parkinson’s disease: objective measures needed for patient stratification in future cause-directed trials
- (2010) Michael G Schlossmacher et al. Biomarkers in Medicine
- Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies
- (2010) Brit Mollenhauer et al. Biomarkers in Medicine
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- The Epidemiology of Dementia Associated with Parkinson's Disease
- (2010) Dag Aarsland et al. BRAIN PATHOLOGY
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
- (2010) Sarah Jesse et al. JOURNAL OF NEUROLOGY
- CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies
- (2010) E. Mulugeta et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cell-Produced -Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
- (2010) E. Emmanouilidou et al. JOURNAL OF NEUROSCIENCE
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study
- (2010) Marios Politis et al. NEUROBIOLOGY OF DISEASE
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Alterations of the blood–brain barrier in cerebral white matter lesions in the ageing brain
- (2010) Julie E. Simpson et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
- (2010) James B. Leverenz et al. PARKINSONISM & RELATED DISORDERS
- Parkinson Disease With Dementia
- (2009) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The neuropathology of probable Alzheimer disease and mild cognitive impairment
- (2009) Julie A. Schneider et al. ANNALS OF NEUROLOGY
- CSF Biomarkers
- (2009) Niklas Mattsson et al. Annals of the New York Academy of Sciences
- The progression of pathology in Parkinson's disease
- (2009) Glenda Margaret Halliday et al. Annals of the New York Academy of Sciences
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Low sensitivity in clinical diagnoses of dementia with Lewy bodies
- (2009) Peter T. Nelson et al. JOURNAL OF NEUROLOGY
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Added diagnostic value of CSF biomarkers in differential dementia diagnosis
- (2009) Nathalie Le Bastard et al. NEUROBIOLOGY OF AGING
- Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies?
- (2009) Roberta Frigerio et al. NEUROBIOLOGY OF AGING
- Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P
- (2009) Karen Koopman et al. NEUROCHEMISTRY INTERNATIONAL
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Clearance and deposition of extracellular α-synuclein aggregates in microglia
- (2008) He-Jin Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
- (2008) Moeko Noguchi-Shinohara et al. BRAIN RESEARCH
- Alpha- and Gamma-Synuclein Proteins Are Present in Cerebrospinal Fluid and Are Increased in Aged Subjects with Neurodegenerative and Vascular Changes
- (2008) E.B. Mukaetova-Ladinska et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia
- (2008) Kurt A. Jellinger Neurodegenerative Diseases
- Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
- (2008) D. Aarsland et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- A more efficient enzyme-linked immunosorbent assay for measurement of α-synuclein in cerebrospinal fluid
- (2007) Wieneke J.A. van Geel et al. JOURNAL OF NEUROSCIENCE METHODS
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now